• LABline
  • Magazine Archive
  • Webinars
  • Whitepapers
  • eBooks
  • Videos
  • Subscribe
    • ID 335137467 © Dzmitry Auramchik | Dreamstime.com
    dreamstime_xxl_335137467
    Genetic Testing

    Can genetic testing predict opioid use disorder risk?

    Erin Brady
    Jan. 10, 2025
    Study from the University of Pennsylvania Perelman School of Medicine and Crescenz VA Medical Center.
    ID 3592783 © Vividpixels | Dreamstime.com
    dreamstime_xxl_3592783
    ID 335593682 | Ai Dna © Doberman84 | Dreamstime.com
    dreamstime_xxl_335593682
    ID 141973761 © Vetre Antanaviciute-meskauskiene | Dreamstime.com
    dreamstime_xxl_141973761
    Courtesy of Roche Diagnostics
    product_ins_6728_im_en
    Courtesy of Thermo Fisher Scientific
    thumbnail_image001
    ID 211428312 © Andrei Ivanov | Dreamstime.com
    dreamstime_xxl_211428312
    MDX

    Fluxergy announces NIAID collaboration

    LABline
    Nov. 21, 2024
    This announcement follows the news of a previous partnership launched earlier this year for Fluxergy.
    ID 208710288 © Noipornpan | Dreamstime.com
    dreamstime_xxl_208710288
    Genomics

    UW–Madison researchers find persistent problems with AI-assisted genomic studies

    LABline
    Nov. 6, 2024
    The faulty predictions are linked to researchers’ use of AI to assist genome-wide association studies.
    ID 322970799 © Leo Rohmann | Dreamstime.com
    dreamstime_xxl_322970799
    Precision Medicine

    NIH clinical trial will test precision medicine treatments for myeloid cancers

    LABline
    Oct. 29, 2024
    Researchers will seek to accelerate the discovery of more tailored treatments for these aggressive cancers of the blood and bone marrow.
    ID 338975729 © Pakawadee Wongjinda | Dreamstime.com
    dreamstime_xxl_338975729
    Genomics

    Genomic variants that increase risk of kidney disease are found in nearly one-third of West Africans

    LABline
    Oct. 29, 2024
    NIH study suggests potential for earlier health interventions for people with West African ancestry.
    ID 88421052 © Mkarco | Dreamstime.com
    dreamstime_xxl_88421052
    MDX

    MLO releases findings of 2024 SOI survey on MDx

    Kara Nadeau
    Oct. 28, 2024
    More quality assurance measures enacted, greater concerns over LDT access, fewer supply chain issues reported among medical laboratory professionals
    ID 332220455 | Ai © Dzmitry Auramchik | Dreamstime.com
    dreamstime_xxl_332220455
    ID 330693766 © Mast3r | Dreamstime.com
    dreamstime_xxl_330693766
    Molecular

    Moffitt study unveils the role of gamma-delta T cells in cancer immunology

    LABline
    Oct. 9, 2024
    Study marks a significant advancement in the understanding of a specific set of immune cells and its role in patient outcomes in cancer therapy.
    ID 127325015 © Dani3315 | Dreamstime.com
    dreamstime_xxl_127325015
    Molecular

    Xcell Biosciences expands AmplifyBio collaboration with unique cell and gene therapy manufacturing capabilities

    LABline
    Oct. 3, 2024
    The AVATAR Foundry system is a cGMP manufacturing platform that delivers novel capabilities for improving the potency of cell and gene therapies.

    Molecular

    ID 99439237 © gopixa | Dreamstime.com
    dreamstime_xxl_99439237
    ID 307018796 © Aaron Amat | Dreamstime.com
    dreamstime_xxl_307018796
    Photo 309524910 © Julija Matuka | Dreamstime.com
    6661ca9ac16d6195f8f80048soi_featureditem
    ID 181887809 © Dmitrii Melnikov | Dreamstime.com
    dreamstime_xxl_181887809
    Photo 95555719 © Nimon Thong Uthai | Dreamstime.com
    Courtesy of IDT